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In January 2012 the Institute of Medicine in the United States
published the report of a consensus study on living well with
chronic illness. The report made 17 recommendations for public
health approaches to chronic disease prevention, surveillance,
data gathering, and chronic disease management programmes
that would help improve quality of life and functioning and
reduce disability.1 Although the report makes some interesting
recommendations (box 1), particularly about research in chronic
disease, and displays a welcome shift in emphasis to “living
well” rather than reducing mortality, it falls short of making the
necessary paradigm shift from a disease based model to one
that focuses on care for patients. This shift in thinking is urgently
needed to provide good care for patients with multiple
comorbidities.
The medical profession faces substantial challenges in caring
for patients with chronic comorbidity well. The taxonomy of
diseases with which we work has accrued piecemeal over the
centuries. Some diagnostic labels have proved immensely useful,
others much less so.2 With the development of numerous
biomarkers for disease, diagnosis has become increasingly
detached from symptoms, to the detriment of those with chronic
illness.
Comorbidity is seen in patients of all ages. Half of people over
65 years of age have at least three coexisting chronic conditions.
One in five has five or more. Although the proportion of patients
who have comorbidities increases in older age groups, the largest
numbers of patients with multiple comorbidities are under 65.3
More than half of patients attending primary care in the UK
have multiple chronic conditions, and such patients take up an
even greater proportion of consultations.4 In a study ofMedicare
beneficiaries, the proportion of patients with more than five
treated conditions increased from 31% to 50% from 1987 to
2002.5 The age adjusted prevalences for hyperlipidaemia,
osteoporosis, and mental disorders increased even more steeply.
It is also worth noting that the diagnoses that are most rapidly
on the rise are those for which new drug treatments are available.
In recent years the single disease model has become an end in
itself as disease management frameworks and targets for single
conditions have become embedded in evidence based guidance
and care pathways. Focus has shifted from patients and their
experience of diseases to measuring parameters of the diseases
themselves. Although evidence based models of single diseases
in isolation work well for patients with one disease, they can
lead to “siloing” of care for people with multiple conditions,
and this can result in chaotic care. One study found that applying
individual disease guidelines to a patient with five chronic
conditions would result in the prescription of 19 doses of 12
different drugs, taken at five time points during the day, and
carrying the risk of 10 attendant interactions or adverse events.6
Care that is “measurably better” may be meaningfully worse
and a nightmare for the patient.
Adverse events related to drugs are among the top five causes
of death in US hospitals, and rates of hospital admission for this
indication in people over 65 are estimated at 17%. This is an
important, expensive, and iatrogenic source of morbidity in
people with multiple chronic conditions that is invisible in
recommendations for care in chronic illness. Research,
guidelines, and models of care seldom support the complex and
difficult decisions about which treatments should not be given
or when to stop treatment. The use of guidelines as standards
enshrines polypharmacy and therapeutic positivism because
this approachmeasures and evaluates quality of care by counting
how often treatments are given, rather than not given. Largely
ignored are the problems of adverse drug effects, and the value
of a patient centred approach to care. However, prioritising these
are the key to reducing morbidity and mortality in patients with
chronic comorbidity and to tackling a financial burden that is
crippling health systems.7 8 9
Chronic illness is characterised by its variability.10 11
Recommendations in guidelines are often based on the average
response in study populations that are usually selected to be
free of comorbidity and polypharmacy. Applying such evidence
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Box 1 Summary of the Institute of Medicine report, Living Well with Chronic Illness1
This detailed literature review uses exemplar conditions including arthritis, survivorship after cancer, chronic pain, dementia, depression,
type 2 diabetes, post-traumatic disabling conditions, schizophrenia, and vision and hearing loss to give broad recommendations. Its main
recommendations are:
• Resources should be used wisely in the current financially difficult environment. The Centers for Disease Control and Prevention
should focus on a select range of diseases
• Research and programme evaluation should provide better scientific and economic evidence on the effectiveness of chronic disease
programmes and models of care
• Focus on quality of life outcome measures for research and programme evaluation and on interventions that reduce the disparity in
healthcare that leads to inequity in outcomes
• Take a more coordinated approach to meeting both health and social needs that facilitates collaboration between population health,
clinical, and non-health services, employers, and community organisations
• Collect better data for surveillance of chronic illnesses as well as the effect of interventions and models of care on patient reported
quality of life outcomes. The report makes specific recommendations for the use and sharing of information from electronic medical
records on coexisting chronic illnesses
• Engage in research on the effects of preventive and lifestyle interventions on both quality of life for people with existing illness and
primary prevention. Find ways to implement prevention effectively
to the treatment of those with comorbidity who are taking a
variety of drugs reduces benefit to an unknown extent and
increases the potential for harm. The evidence base for the effect
of treatments in the context of comorbidity is poor and does not
account for variability in the genesis, expression, and
progression of illness; the interaction of illnesses; the
physiological damage caused by the stress from life events; and
the impact of biopsychosocial interventions.10-12 There are few
studies in the very elderly. In this group, explanatory models
and interventions extrapolated from studies of younger patients
do not necessarily work or match patients’ priorities for care.13-15
Healthcare systems that are underpinned by strong generalist
primary care produce better health outcomes for patients with
chronic illness at lower cost and with less health inequality than
those that are not.9Specialists provide better condition specific
care measured by guideline adherence for patients with single
conditions, but generalists provide better care for those with
multiple conditions.9 This may be because generalist care is
pragmatic and iterative, and it is based around the symptoms,
values, and priorities of the particular person rather than
particular diseases. Generalist care has the potential for
“quarternary prevention”—that is, protecting patients from
gratuitous diagnostic labels, tests, and treatments that offer no
benefit with regard to mortality and morbidity and are driven
by misplaced goodwill or commercial interests.12 However, all
these attributes are being rapidly eroded in the face of payment
by results and a system that evaluates the quality of care and of
doctors on the basis of siloed adherence to evidence based
guidelines for single diseases. This move carries the potential
to disempower doctors and patients and prevent them from using
their observation of individual responses and needs.
There is a pressing need to reverse the current trend towards
management of individual diseases in silos so that care of
patients with chronic comorbid illness is much more closely
driven by their particular symptoms, needs, and treatment effects
and their own priorities for care. An improvement in health
status must be seen not as an end in itself but as the means to
fulfilment and possibility in the life of the patient. Furthermore,
healthcare systems need to start to value and provide adequate
support for the kind of iterative generalist care that focuses more
on the person than on the disease entity and the necessary
variation this entails. This would place equal value on the art
of “not doing”—making complex decisions not to give
treatments, not to order tests, and to stop current treatments
when in the best interests of the patient.
To achieve this, uncomfortable shifts in research, evidence based
guidance, and systems and funding of care are needed (box 2).
While routinely collected data are useful for research, they
almost invariably comprise data linked to single diagnoses, and
information from the real world testing of treatment effects and
systems of care among huge numbers of patients with multiple
illnesses remains largely invisible. Technologies such as
electronic medical records that include patient input are
potentially useful in dealing with these problems, but only if
both their form and function go beyond diagnostic labels and
make visible the patients’ individual symptomatic pattern of
comorbidity along with their identified priorities for care. If
patients with chronic comorbidity are to get the best from
medical care, there is an urgent need for these different ways
of thinking—beyond diagnoses. In the words ofWilliam Osler:
“It is more important to know what type of person has the
disease than to know what type of disease the person has.”
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Box 2 Summary points
The piecemeal rise of diagnostic labels and biomarkers for illness has led to diagnosis that is often detached from symptoms
Current single disease approaches to research and guidelines encourages siloing of care that can be harmful, complex, and time
consuming for patients with chronic comorbidity, and burdensome for health systems
Research rarely investigates, and guidelines rarely support, complex and difficult decisions about when to stop or not give treatments
Care for patients with chronic comorbid illness must be more closely driven by patients’ individual experience of illness and treatment
effects, and their priorities for care
Shifts in the frameworks of research, guidance, and funding, in addition to changes in the values and technologies underpinning healthcare
systems, are needed to ensure care that focuses on the person rather than management that focuses on diseases
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